These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9205823)

  • 1. Endotoxin depresses hepatic cytochrome P450-mediated drug metabolism in women.
    Shedlofsky SI; Israel BC; Tosheva R; Blouin RA
    Br J Clin Pharmacol; 1997 Jun; 43(6):627-32. PubMed ID: 9205823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism.
    Shedlofsky SI; Israel BC; McClain CJ; Hill DB; Blouin RA
    J Clin Invest; 1994 Dec; 94(6):2209-14. PubMed ID: 7989576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent effects of Klebsiella pneumoniae endotoxin on hepatic drug-metabolizing enzyme activity in rats.
    Nadai M; Sekido T; Matsuda I; Li W; Kitaichi K; Itoh A; Nabeshima T; Hasegawa T
    J Pharm Pharmacol; 1998 Aug; 50(8):871-9. PubMed ID: 9751451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients.
    Israel BC; Blouin RA; McIntyre W; Shedlofsky SI
    Br J Clin Pharmacol; 1993 Sep; 36(3):229-35. PubMed ID: 9114909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The suppressive effects of lipopolysaccharide-induced acute phase response on hepatic cytochrome P450-dependent drug metabolism in rabbits.
    Saitoh T; Kokue E; Shimoda M
    J Vet Pharmacol Ther; 1999 Apr; 22(2):87-95. PubMed ID: 10372593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of acute phase response on the plasma clearance of antipyrine, theophylline, phenytoin and nifedipine in rabbits.
    Saitoh T; Kokue E; Shimoda M
    J Vet Pharmacol Ther; 2000 Jun; 23(3):153-8. PubMed ID: 11110102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipyrine, theophylline, and hexobarbital as in vivo P450 probe drugs.
    Groen K; Breimer DD
    Methods Enzymol; 1996; 272():169-77. PubMed ID: 8791775
    [No Abstract]   [Full Text] [Related]  

  • 8. Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters.
    Ueyama J; Nadai M; Kanazawa H; Iwase M; Nakayama H; Hashimoto K; Yokoi T; Baba K; Takagi K; Takagi K; Hasegawa T
    Eur J Pharmacol; 2005 Mar; 510(1-2):127-34. PubMed ID: 15740733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased antipyrine clearance following endotoxin administration: in vivo evidence of the role of nitric oxide.
    Kitaichi K; Wang L; Takagi K; Iwase M; Shibata E; Nadai M; Hasegawa T
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2697-701. PubMed ID: 10543749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between the metabolism of antipyrine, hexobarbitone and theophylline in man as assessed by a 'cocktail' approach.
    Schellens JH; van der Wart JH; Danhof M; van der Velde EA; Breimer DD
    Br J Clin Pharmacol; 1988 Oct; 26(4):373-84. PubMed ID: 3190987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach.
    Schellens JH; Janssens AR; van der Wart JH; van der Velde EA; Breimer DD
    Eur J Clin Invest; 1989 Oct; 19(5):472-9. PubMed ID: 2511024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pioglitazone on endotoxin-induced decreases in hepatic drug-metabolizing enzyme activity and expression of CYP3A2 and CYP2C11.
    Ueyama J; Kitaichi K; Nadai M; Iwase M; Tomyo N; Kanazawa H; Suzuki R; Takagi K; Takagi K; Hasegawa T
    Eur J Pharmacol; 2004 Sep; 498(1-3):257-65. PubMed ID: 15364003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative disposition of pharmacologic markers for cytochrome P-450 mediated metabolism, glomerular filtration rate, and extracellular and total body fluid volume of Greyhound and Beagle dogs.
    KuKanich B; Coetzee JF; Gehring R; Hubin M
    J Vet Pharmacol Ther; 2007 Aug; 30(4):314-9. PubMed ID: 17610404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of hexobarbitone and antipyrine in DOCA-hypertensive rats.
    Ben-Zvi Z; Hreash F; Kaplanski J
    J Pharm Pharmacol; 1991 May; 43(5):349-52. PubMed ID: 1680178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation.
    Engel G; Hofmann U; Heidemann H; Cosme J; Eichelbaum M
    Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis.
    Masubuchi Y; Horie T
    Drug Metab Dispos; 2004 Apr; 32(4):437-41. PubMed ID: 15039297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in mice.
    Shedlofsky SI; Swim AT; Robinson JM; Gallicchio VS; Cohen DA; McClain CJ
    Life Sci; 1987 Jun; 40(24):2331-6. PubMed ID: 3295445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and elimination of antipyrine in man: an analysis of 298 patients classified by type of diabetes, age, sex, duration of disease and liver involvement.
    Sotaniemi EA; Pelkonen O; Arranto AJ; Tapanainen P; Rautio A; Pasanen M
    Pharmacol Toxicol; 2002 Mar; 90(3):155-60. PubMed ID: 12071338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of zidovudine therapy in patients with HIV infection on endogenous interferon plasma levels and the hepatic cytochrome P450 enzyme system.
    Brockmeyer NH; Barthel B; Mertins L; Goos M
    Chemotherapy; 1998; 44(3):174-80. PubMed ID: 9612607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans.
    Poloyac SM; Tosheva RT; Gardner BM; Shedlofsky SI; Blouin RA
    Clin Pharmacol Ther; 1999 Dec; 66(6):554-62. PubMed ID: 10613610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.